Variant Reinterpretation/Reclassification Note

Note Type: Variant Reinterpretation/Reclassification Note

Author/Credentials: [Author name and credentials]

Date: [Date of note]

Encounter Context: [phone / telehealth / chart review / in-person]

Patient Identifiers: [Per institutional standard]

Associated Testing

• Laboratory and Test Type: [Laboratory name]; [Test type/method]
• Original Report: [Report date]; [Accession/Specimen ID]
• Amended Report: [Amended report date]; [Accession/Specimen ID] (If no amended laboratory report exists, state this explicitly and note whether the clinic's interpretation is provisional pending laboratory amendment and whether the laboratory was contacted.)

Reason for Reinterpretation

• Trigger: [Lab-initiated amendment / clinician request / patient request / new phenotype or family history / new literature or database evidence / other]
• Requester and Date: [Name/role]; [Date of request]
• Patient Recontact Preferences: [Previously documented preferences regarding updates, if any]
• Urgency: [Urgency context, e.g., pregnancy, upcoming procedure] (Only include if applicable)

Prior Interpretation and Counseling

• Original Testing Indication: [Indication/referral reason]
• Prior Variant(s) and Classification(s): [Variant(s); prior classification(s)]
• Initial Disclosure: [Date and modality]; [Key counseling points conveyed]
• Clinical Actions Based on Prior Classification: [Actions/interventions/referrals taken]

Interval Updates

(Include this section only if new information since the original report informed reinterpretation; otherwise omit entirely.)

• Updated Personal History/Phenotype: [New or evolving features]
• Updated Family History: [New diagnoses/events in relatives]
• New Testing: [Patient/relative testing and results; note segregation data if applicable]
• History Outreach: [If updated history unavailable, note outreach attempted and outcome]

Evidence Review

• Date Range of Review: [Start date] – [End date]
• Sources Consulted: [Literature databases / ClinVar / population databases / functional studies / disease guidelines / other]
• Previously Known Evidence: [Concise summary]
• New Evidence Since Prior Interpretation: [Concise summary]

Variant-Specific Review

(Repeat this subsection for each variant under review.)

• Variant: [Gene]; [HGVS nomenclature]; [Reference transcript]
• Associated Condition and Inheritance: [Condition]; [Autosomal dominant / autosomal recessive / X-linked / other]
• What Changed Since Prior Interpretation: [New data impacting classification]
• Criteria Applied (ACMG/AMP):
  • [Criterion code]: [One-line justification]
  • [Criterion code]: [One-line justification]
  • [Criterion code]: [One-line justification]
• Conflicting Evidence and Weighting: [Conflicts and rationale for weighting] (Omit if none)

Clinic Counseling Interpretation (Pending Laboratory Amendment): [Clinic interpretation; laboratory contact status with date/method] (Only include if providing interpretation without an amended laboratory report.)

Reclassification Outcome

• Classification Change: [Prior classification] → [New classification] ([Effective date]; [laboratory / clinic provisional])
• Molecular Diagnosis Status: [Changed / unchanged]; [Brief impact on diagnosis if any]
• Key Evidence Drivers:
  • [Driver 1]
  • [Driver 2]
  • [Driver 3]

(If classification is unchanged after review, state: "Reinterpretation completed; classification unchanged.")

Recommendations

Patient Recommendations

• [Screening/surveillance changes with supporting guideline source]
• [Risk-reducing interventions, if supported by guidelines]
• [Referrals to relevant specialists]
• [Additional or confirmatory testing warranted]

(If no management changes resulted, state explicitly. If variant remains VUS, document that the variant should not be used as the sole basis for irreversible medical decisions.)

Family Recommendations

• [Relatives who may benefit from targeted testing]
• [Implications of a positive result for relatives]
• [Segregation testing that may aid interpretation]
• [Reproductive counseling implications] (If applicable)

Recontact and Disclosure Documentation

(Use as audit trail. Include only entries that occurred; omit unused placeholders.)

Contact Attempts

• [Date/time] — [phone / portal / letter / other] — [reached / voicemail / no response / undeliverable] — [Next planned attempt or closure reason]
• [Additional attempts as needed]

Disclosure Encounter

• Date/Time and Modality: [Date/time]; [phone / telehealth / in-person]
• Participants: [Names/roles; interpreter if used]
• Key Information Communicated: [Classification change; implications; limitations; next steps]
• Patient Questions/Concerns: [Summary]
• Confirmation of Understanding: [Teach-back summary, e.g., "Patient summarized: '...'"]
• Preferences for Future Updates: [Preferences and preferred contact method]

Ordering Clinician Notification: [Yes / No]; [Details if patient could not be reached]

Care Coordination

• EHR Filing: [Location of amended report/attachments in record]
• Clinicians Notified: [Ordering provider, PCP, specialists notified; date/method]
• Patient Copy Provided: [Yes / No]; [Method]
• Follow-Up: [Appointment timeframe]; [Responsible party for scheduling]

Limitations

Variant interpretation may change as new evidence emerges. This note reflects evidence reviewed as of [date of review]. Future recontact depends on current contact information and patient-stated preferences.

Author Signature: [Typed name, credentials, date/time]